GSK-206901

Study Sponsor: GSK

Study Title

A randomized, open-label, cross-over, placebo inhaler study to evaluate the correct use of ELLIPTA™ dry powder inhaler (DPI) compared to DISKUS™ DPI used in combination with HandiHaler DPI in participants with Chronic Obstructive Pulmonary Disease (COPD)

Medicine or Vaccine (generic name)

fluticasone furoate/vilanterol/umeclidinium bromide

Sponsor Identification Number

206901

Trial Registry Identification Number(#'s)

NCT03227445

Medical Condition

Pulmonary Disease, Chronic Obstructive

Phase

Phase 4

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=206901

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT03227445

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

May 2020